Introduction
Recent automated hematology analyzers (HAs) can identify and report nucleated red blood cells (NRBC) count as a separate population out of white blood cells (WBC). The aim of this study ...was to investigate the analytical performances of NRBC enumeration on five top of the range HAs.
Methods
We evaluated the within‐run and between‐day precision, limit of blank (LoB), limit of detection (LoD), and limit of quantitation (LoQ) of XE‐2100 and XN‐module (Sysmex), ADVIA 2120i (Siemens), BC‐6800 (Mindray), and UniCel DxH 800 (Beckman Coulter). Automated NRBC counts were also compared with optical microscopy (OM).
Results
The limits of detection for NRBC of the BC‐6800, XN‐module, XE‐2100, UniCel DxH 800, and ADVIA 2120i are 0.035×109/L, 0.019×109/L, 0.067×109/L, 0.038×109/L, and 0.167×109/L, respectively. Our data indicated excellent performance in terms of precision. The agreement with OM was excellent for BC‐6800, XN‐module, and XE‐2100 (Bias 0.023, 0.019, and 0.033×109/L, respectively). ADVIA 2120i displayed a significant constant error and UniCel DxH 800 both proportional and small constant error.
Conclusion
Regards to NRBC counting, the performances shown by BC‐6800, XN‐module, and XE‐2100 are excellent also a low count, ADVIA 2120i and UniCel DxH 800 need to be improved.
Background
The aims of this study were to compare the diagnostic accuracy of blood smear review criteria, by means of three different panel rules, those proposed by: the International Consensus Group ...for Hematology 41‐ICGH rules, the Italian Survey IS rules and the Working Group on Hematology‐SIBioC (WGH) consensus rules (WGH rules).
Methods
This study is based on 2707 peripheral blood (PB) samples referred for routine hematological testing to the WGH‐associated laboratories displaced all over the Italian territory. The PB samples were processed on seven different hematology analyzers (HAs): Advia 2120i, XE‐2100, BC‐6800, ABX Pentra, XN‐1000, Cell‐DYN Sapphire, and DxH800, respectively. All the results provided by the HAs were analyzed through the application of three different blood smear review criteria: that is, the 41‐ICGH, IS, and WGH rules. Finally, data were compared with those obtained by optical microscopy (OM), as the current gold standard.
Results
The overall the agreement OM classification with ICGH, IS, and WGH panel rules is 0.83, 0.83, and 0.85, respectively. The false negatives are 2.1%, 3.0%, and 2.9%, while false positives are 15.1%, 13.7%, and 11.7%, respectively. All the seven HAs showed variable interinstrument performance, as three different criteria for OM review were adopted on each of them from time to time.
Conclusion
These results presented show that the customization of validation rules is necessary for enhancing the quality of hematological testing and optimizing workflow.
Bioartificial polymeric materials based on blends of dextran and poly(vinyl alcohol-
co-acrylic acid) P(VA-
co-AA) were prepared in the form of films and characterised to evaluate the miscibility of ...the natural component with the synthetic one. The idea of this work was to compatibilise PVA and dextran by introducing carboxylic groups along the PVA chains.
The copolymer was synthesised and characterised in our laboratories. The results evidenced that the copolymer had an appropriate molecular weight and the content of PAA in the copolymer was 45% (weight). Then, films with different composition ratios were prepared by solution casting and analysed by differential scanning calorimetry (DSC), scanning electron microscopy (SEM), infrared spectroscopy (FT-IR), thermogravimetric analysis (TGA), chemical imaging analysis and mechanical tests. The results obtained indicated that the introduction of carboxylic groups along the PVA chains had a positive effect on the miscibility degree of the synthetic component with the biological one.
Display omitted
Cancer therapy often relies on the combined action of different molecules to overcome drug resistance and enhance patient outcome. Combined strategies relying on molecules with ...different pharmacokinetics often fail due to the lack of concomitant tumor accumulation and, thus, to the loss of synergistic effect. Due to their ability to enhance treatment efficiency, improve drug pharmacokinetics, and reduce adverse effects, polymer nanoparticles (PNPs) have been widely investigated as co-delivery vehicles for cancer therapies. However, co-encapsulation of different drugs and probes in PNPs requires a flexible polymer platform and a tailored particle design, in which both the bulk and surface properties of the carriers are carefully controlled. In this work, we propose a core-shell PNP design based on a polyurethane (PUR) core and a phospholipid external surface. The modulation of the hydrophilic/hydrophobic balance of the PUR core enhanced the encapsulation of two chemotherapeutics with dramatically different water solubility (Doxorubicin hydrochloride, DOXO and Docetaxel, DCTXL) and of Iron Oxide Nanoparticles for MRI imaging. The outer shell remained unchanged among the platforms, resulting in un-modified cellular uptake and in vivo biodistribution. We demonstrate that the choice of PUR core allowed a high entrapment efficiency of all drugs, superior or comparable to previously reported results, and that higher core hydrophilicity enhances the loading efficiency of the hydrophilic DOXO and the MRI contrast effect. Moreover, we show that changing the PUR core did not alter the surface properties of the carriers, since all particles showed a similar behavior in terms of cell internalization and in vivo biodistribution. We also show that PUR PNPs have high passive tumor accumulation and that they can efficient co-deliver the two drugs to the tumor, reaching an 11-fold higher DOXO/DCTXL ratio in tumor as compared to free drugs.
Exploiting the synergistic action of multiple chemotherapeutics is a promising strategy to improve the outcome of cancer patients, as different agents can simultaneously engage different features of tumor cells and/or their microenvironment. Unfortunately, the choice is limited to drugs with similar pharmacokinetics that can concomitantly accumulate in tumors. To expand the spectrum of agents that can be delivered in combination, we propose a multi-compartmental core-shell nanoparticles approach, in which the core is made of biomaterials with high affinity for drugs of different physical properties. We successfully co-encapsulated Doxorubicin Hydrochloride, Docetaxel, and contrast agents and achieved a significantly higher concomitant accumulation in tumor versus free drugs, demonstrating that nanoparticles can improve synergistic cancer chemotherapy.
Bacterial infections are a growing concern to the health care systems. Bacteria in the human body are often found embedded in a dense 3D structure, the biofilm, which makes their eradication even ...more challenging. Indeed, bacteria in biofilm are protected from external hazards and are more prone to develop antibiotic resistance. Moreover, biofilms are highly heterogeneous, with properties dependent on the bacteria species, the anatomic localization, and the nutrient/flow conditions. Therefore, antibiotic screening and testing would strongly benefit from reliable
models of bacterial biofilms. This review article summarizes the main features of biofilms, with particular focus on parameters affecting biofilm composition and mechanical properties. Moreover, a thorough overview of the in vitro biofilm models recently developed is presented, focusing on both traditional and advanced approaches. Static, dynamic, and microcosm models are described, and their main features, advantages, and disadvantages are compared and discussed.
A technical and economical analysis of the application of a membrane separation technique for the purification of wastewaters aimed at their reuse is described. The investigation has been carried out ...by treating wastewaters of a pilot plant, reproducing on a smaller scale a separation system based on ultrafiltration and reverse osmosis. Significant indications for the exploitation of this approach on the fulling industrial scale were gained during the work. The effluent from dyeing and finishing plants, after activated sludge oxidation, was treated at an 800 l/h by means of sand filtration, followed by a separation in an ultrafiltration membrane module. The last separation step, reverse osmosis at 8 bar pressure, produced a permeate (60% of the inlet flow) that, relying on the analytical screening performed, was of much better quality with respect to process water presently in use. Therefore the permeate produced can be re-used in all production steps, including the most demanding ones concerning water quality such as dyeing with light coloration. A preliminary analysis of investment and operating costs also gave encouraging indications of the economic feasibility of the approach.
Abstract Background The advancement of knowledge in the field of regenerative medicine is increasing the therapeutic expectations of patients and clinicians on cell therapy approaches. Within these, ...stem cell therapies are often evoked as a possible therapeutic option for diabetes, already ongoing or possible in the near future. Aim The purpose of this document is to make a point of the situation on existing knowledge and therapies with stem cells to treat patients with diabetes by focusing on some of the aspects that most frequently raise curiosity and discussion in clinical practice and in the interaction with the patient. In fact, at present there are no clinically approved treatments based on the use of stem cells for the treatment of diabetes, but several therapeutic approaches have already been evaluated or are being evaluated in clinical trials. Data synthesis It is possible to identify three large potential application fields: 1) the reconstruction of the β cell mass; 2) the immunomodulation in type 1 diabetes (T1D); 3) the treatment of complications. In this study we will limit the discussion to approaches that have the potential for clinical translation, deliberately omitting aspects of basic biology and preclinical data. Also, we intentionally omit the treatment of the complications that will be the subject of a future document. Finally, an overview of the Italian situation regarding the storage of cord blood cells for the therapy of diabetes will be given.
The experimental results of the pilot scale application of different membrane technologies, supported by clariflocculation and ozonization, for textile wastewater reuse are described. The ...investigation has been carried out by treating two different textile effluents: a secondary effluent coming from a biological activated plant and a wastewater coming directly from several textile departments. In the first case the pilot plant used sand filtration and microflitration (MF) as pre-treatments for nanofiltration (NF). The MF and NF membranes tested were of the spiral wound type. The NF permeate can be reused in all production steps, including dyeing with light coloration. In the second case, the chemical-physical pre-treatment and the advanced treatment of water have been experimented for different kind of wastewater (from the carbonising process, from dyeing and fulling). The most interesting experimental results were obtained from the treatment of wastewater from the carbonising process. A scheme process in which ultrafiltration (UF) with flat membranes operating under vacuum is placed downstream an ozonization treatment has been evaluated. The UF permeate quality was suitable to the reuse in production processes.
PDF
